Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Generation and preclinical characterization of an antibody specific for SEMA4D.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Immunity and inflammation in neurodegenerative diseases.
Early detection of thrombin activity in neuroinflammatory disease.
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
Construction and validation of the chronic acquired polyneuropathy patient-reported index, "CAP-PRI:" a disease-specific, health-related quality of life instrument.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]
Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Tumefactive demyelinating disease with isolated spinal cord involvement.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
The new era of multiple sclerosis therapy.
The therapeutic use of cannabinoids: Forensic aspects.
Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica.
Therapies for multiple sclerosis: translational achievements and outstanding needs.
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.

Pages